Cargando…
Matrix rigidity regulates a switch between TGF-β1–induced apoptosis and epithelial–mesenchymal transition
The transforming growth factor-β (TGF-β) signaling pathway is often misregulated during cancer progression. In early stages of tumorigenesis, TGF-β acts as a tumor suppressor by inhibiting proliferation and inducing apoptosis. However, as the disease progresses, TGF-β switches to promote tumorigenic...
Autores principales: | Leight, Jennifer L., Wozniak, Michele A., Chen, Sophia, Lynch, Michelle L., Chen, Christopher S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The American Society for Cell Biology
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3290638/ https://www.ncbi.nlm.nih.gov/pubmed/22238361 http://dx.doi.org/10.1091/mbc.E11-06-0537 |
Ejemplares similares
-
Lack of extracellular matrix switches TGF-β induced apoptosis of endometrial cells to epithelial to mesenchymal transition
por: Ruiz-Mitjana, Anna, et al.
Publicado: (2022) -
TGF-β regulates isoform switching of FGF receptors and epithelial–mesenchymal transition
por: Shirakihara, Takuya, et al.
Publicado: (2011) -
Prostate apoptosis response-4 mediates TGF-β-induced epithelial-to-mesenchymal transition
por: Chaudhry, P, et al.
Publicado: (2014) -
TRPV4 regulates matrix stiffness and TGFβ1‐induced epithelial‐mesenchymal transition
por: Sharma, Shweta, et al.
Publicado: (2018) -
Formin-dependent TGF-β signaling for epithelial to mesenchymal transition
por: Rana, Manish K., et al.
Publicado: (2018)